Solexa Q3 Revenues Fall 33 Percent as Company Shifts from MPSS to Sequencing

Nov 13, 2006

NEW YORK (GenomeWeb News) - Solexa today said third-quarter revenues decreased 33 percent as R&D spending rose 21 percent and its net loss decreased 8 percent.

Total receipts for the three months ended Sept. 30 fell to $569,000 from $844,000 in the third quarter of 2005. Solexa said all of its revenues are from its legacy MPSS technology, which the company has now discontinued, and do not include any contribution from its Genome Analysis System DNA sequencing technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

The Fall of the Yellow-Banded Bumblebee

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

If It Is to Help

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

Bunch at Once

The Scientist reports agricultural researchers are working on a gene-stacking tool.

This Week in Nature

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.

Featured White Papers

The Ultimate Guide to Mouse Clinical Trials

Sep

17

Featured Webinar

Trends in Clinical NGS QC Management: Expert Insights to Ensure Quality Results for Your Lab

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Main menu